Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))

BACKGROUND: A range of plasma volume expanders is used clinically, often in settings where haemostasis may already be impaired. The haemostatic agent, recombinant activated factor VII (rFVIIa, NovoSeven(®)), may be used to improve haemostasis but potential interactions with different volume expander...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Viuff, D., Lauritzen, B., Pusateri, A. E., Andersen, S., Rojkjaer, R., Johansson, P. I.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2008
Sujets:
Cardiovascular
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2517151/
https://ncbi.nlm.nih.gov/pubmed/18565966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/bja/aen175
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires